Consonance Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Consonance Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,373,924	Closed	-$16.4M	–	45
2020 Q4	$16.4M	Sell	2,373,924 -1,471,070	-38%	-$9.41M	1.53%	21
2020 Q3	$21.7M	Sell	3,844,994 -805,571	-17%	-$3.84M	2.64%	16
2020 Q2	$23.7M	Buy	4,650,565 +1,500,000	+48%	+$6.25M	1.42%	20
2020 Q1	$10.8M	Sell	3,150,565 -275,800	-8%	-$1.61M	0.81%	26
2019 Q4	$29.4M	Buy	+3,426,365	New	+$12.2M	1.79%	22
2014 Q2	–	Sell	-311,287	Closed	-$11.1M	–	29
2014 Q1	$11.1M	Buy	+311,287	New	+$10.5M	1.65%	22

Other funds holding ISEE

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

YCM

Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

Consonance Capital Management's ISEE Position: Q1 2021 in Review

Consonance Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2021, closing a stake of 2,373,924 shares — an estimated $16.4M sold.

Consonance Capital Management first reported a position in ISEE in Q1 2014 and held it in 6 quarters. The position peaked at $29.4M in Q4 2019. 115 funds tracked by Wall St. Rank hold ISEE as of Q1 2021.

Consonance Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Consonance Capital Management sold 2,373,924 IVERIC bio, Inc. Common Stock shares in Q1 2021, an estimated $16.4M.
Consonance Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 6 quarters.
Consonance Capital Management's IVERIC bio, Inc. Common Stock position peaked at $29.4M in Q4 2019.
115 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2021.

Based on Consonance Capital Management's 13F filing for Q1 2021, filed 17 May 2021.